继发性心肌病特指心肌病变是由其他疾病、免疫或环境因素等引起的心脏扩大的病变。根据临床病程的发展,继发性心脏病可分为早期、中期和晚期,临床表现为进行性心脏扩大、收缩功能损害及不同程度的心力衰竭症状。由于继发性心脏病的临床表现和原发性相似,因此临床上误诊病例并非少见,针对错误的病因施治,往往贻误治疗。本文就临床药师在1例继发性心肌病患者的药物治疗过程中,参与患者个体化给药方案的制订,针对治疗方案及药物的联合应用 Secondary cardiomyopathy refers to myocardial disease is caused by other diseases, immune or environmental factors caused by the expansion of the heart disease. According to the development of clinical course, secondary heart disease can be divided into early, middle and late clinical manifestations of progressive heart enlargement, systolic dysfunction and varying degrees of heart failure symptoms. Because of the clinical manifestations of secondary heart disease and primary similar, so the clinical misdiagnosis of cases is not uncommon, for the wrong etiology, often delaying treatment. In this paper, clinical pharmacists in 1 case of patients with secondary cardiomyopathy in the course of drug treatment, the individual patient involved in the development of drug programs, the combination of treatment options and drugs